INTEST CORP|4Mar 10, 4:36 PM ET

Gilmour Duncan 4

4 · INTEST CORP · Filed Mar 10, 2023

Form 4

Period: 2023-03-08

CFO, Treasurer & Secretary

Transactions

Award
Common Stock
2023-03-08+4,672→ 26,276 total
Award
Common Stock
2023-03-08+4,670→ 30,946 total
Award
Employee Stock Option (right to buy)
2023-03-08+8,044→ 8,044 total
Exercise: $16.06Exp: 2033-03-07→ Common Stock (8,044 underlying)

Holdings

Common Stock
(indirect: By Spouse)
200
Employee Stock Option (right to buy)
Exercise: $16.80Exp: 2031-06-13→ Common Stock (8,104 underlying)
8,104
Employee Stock Option (right to buy)
Exercise: $9.76Exp: 2032-03-08→ Common Stock (12,848 underlying)
12,848

Footnotes (5)

[F1]These restricted shares were granted pursuant to the Issuer's Fourth Amended and Restated 2014 Stock Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 8, 2024
[F2]These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest on March 8, 2026 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 7,005.
[F3]This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 8, 2024
[F4]This option vests in four equal annual installments commencing on March 9, 2023.
[F5]This option vests in four equal annual installments commencing on June 14, 2022.

Documents

1 file